Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Whitehawk Therapeutics (WHWK) Times Interest Earned (2020 - 2024)

Whitehawk Therapeutics (WHWK) has disclosed Times Interest Earned for 4 consecutive years, with -$352.97 as the latest value for Q3 2024.

  • On a quarterly basis, Times Interest Earned fell 14.7% to -$352.97 in Q3 2024 year-over-year; TTM through Jun 2025 was -$2692.9, a 780.36% decrease, with the full-year FY2024 number at -$438.04, down 40.67% from a year prior.
  • Times Interest Earned was -$352.97 for Q3 2024 at Whitehawk Therapeutics, down from -$268.69 in the prior quarter.
  • In the past five years, Times Interest Earned ranged from a high of -$17.07 in Q2 2021 to a low of -$553.7 in Q3 2021.
  • A 4-year average of -$272.2 and a median of -$290.09 in 2023 define the central range for Times Interest Earned.
  • Biggest YoY gain for Times Interest Earned was 53.18% in 2022; the steepest drop was 1786.91% in 2022.
  • Whitehawk Therapeutics' Times Interest Earned stood at -$199.31 in 2021, then crashed by 36.19% to -$271.44 in 2022, then decreased by 14.49% to -$310.77 in 2023, then fell by 13.58% to -$352.97 in 2024.
  • Per Business Quant, the three most recent readings for WHWK's Times Interest Earned are -$352.97 (Q3 2024), -$268.69 (Q2 2024), and -$336.41 (Q1 2024).